Cervicogenic HeadacheNCT07067242
Prevalence of Cervicogenic Headache in Lab Technicians
An observational study of Cervicogenic Headache, run by Elite College of Management Sciences, Gujranwala, Pakistan at 1 site in Pakistan.
Trial summary
The purpose of the study is to determine the prevalence of cervicogenic headache among lab technicians Read more about this study
- Who is it for?
- Ages 30 to 44 yearsHealthy volunteers can take part
- Conditions the study is for
- Cervicogenic Headache
- How many people
- 217 participants
- Where
- 1 sitePakistan
- Study dates
- 15 Apr 2025to 3 Jul 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 44 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Lab technicians of Gujranwala
Who may be able to join
- Sitting duration of 3 or more than 3 hours
- Having neck pain for atleast1 month
- Consistant Unilateral headache
- Age 30 to 44
Who cannot join
- Recent fracture
- Recent surgery
- Congenital conditions of cervical spine
- History of traumatic neck injuries or cervical spine surgery
- Diagnosis of primary headache disorders (e.g., migraines, tension-type headaches).(21)
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Private and public labs of Gujranwala
Chak One Hundred Seventy-five Nine Left, Punjab Province
About this study
Official title: Prevalence of Cervicogenic Headache Among Lab Technicians
The purpose of the study is to determine the prevalence of cervicogenic headache among lab technicians
Read the detailed description
Cervicogenic headache is a type of headache characterized by chronic hemi- cranial pain referred to the head from either the cervical spine or soft tissues within the neck .It reduces the quality of life .
Objective: The objective of this study is to determine the prevalence of cervico-genic headache among lab technicians in Gujranwala.
- Conditions
- Cervicogenic Headache
- Keywords
- Cervicogenic headache, Posture, Neck pain, Lab technicians
- Medical subject headings
- Post-Traumatic Headache, Neck Pain
What is being measured
The primary outcome is the main question the study is designed to answer.
Numeric Pain Rating Scale
The Numeric Pain Rating Scale (NPRS) is a commonly used tool to measure a patient's pain intensity in a quick and simple way. Patients are asked to rate their pain on a numeric scale from 0 to 10. 0 represents no pain, while 10 represents the worst possible pain
Measured: 4 weeks
Self prepared questionnaire
To measure Cervicogenic headache associated disability
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jul 2025
- Study start15 Apr 2025
- Primary completion30 Jun 2025
- Study completion3 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (11)Papers the sponsor has linked to this study.
- Other trials for Cervicogenic HeadacheStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 217 participants (actual)
Sponsor and investigators
- Lead sponsor
- Elite College of Management Sciences, Gujranwala, Pakistan
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Rukhma Mauzzam, Principal investigator, Elite College of Management Science
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07067242
- Sponsor's protocol ID
- 2020-GCUF079345
- Status last verified
- May 2026
- First submitted
- 5 Jul 2025
- Last updated
- 8 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Young IA, Dunning J, Butts R, Cleland JA, Fernandez-de-Las-Penas C. Psychometric properties of the Numeric Pain Rating Scale and Neck Disability Index in patients with cervicogenic headache. Cephalalgia. 2019 Jan;39(1):44-51. doi: 10.1177/0333102418772584. Epub 2018 Apr 19.
PubMed 29673262Sjaastad O, Bakketeig LS. Prevalence of cervicogenic headache: Vaga study of headache epidemiology. Acta Neurol Scand. 2008 Mar;117(3):173-80. doi: 10.1111/j.1600-0404.2007.00962.x. Epub 2007 Nov 20.
PubMed 18031563Knackstedt H, Bansevicius D, Aaseth K, Grande RB, Lundqvist C, Russell MB. Cervicogenic headache in the general population: the Akershus study of chronic headache. Cephalalgia. 2010 Dec;30(12):1468-76. doi: 10.1177/0333102410368442. Epub 2010 May 19.
PubMed 2097460718. Kanniappan, V., Abraham, S. S., & Veeragoudhaman, T. S. (2022). PREVALENCE OF CERVICOGENIC HEADACHE AMONG YOUNG POPULATION. International Journal of Research-GRANTHAALAYAH, 10(9), 14-26.
Almesned IS, Alqahtani NG, Alarifi JA, Alsaawy TN, Agha S, Alhumaid MA. Prevalence of primary headache among medical students at King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. J Family Med Prim Care. 2018 Nov-Dec;7(6):1193-1196. doi: 10.4103/jfmpc.jfmpc_240_18.
PubMed 30613496Muayqil T, Al-Jafen BN, Al-Saaran Z, Al-Shammari M, Alkthiry A, Muhammad WS, Murshid R, Alanazy MH. Migraine and Headache Prevalence and Associated Comorbidities in a Large Saudi Sample. Eur Neurol. 2018;79(3-4):126-134. doi: 10.1159/000487317. Epub 2018 Mar 14.
PubMed 2953961010. Mathur, R., & Tegh, S. S. A Cross-Sectional Study on the Prevalence of Cervicogenic Headache Amongst University Students.
Fortner MO, Woodham TJ, Oakley PA, Harrison DE. Is the cervical lordosis a key biomechanical biomarker in cervicogenic headache?: a Chiropractic Biophysics(R) case report with follow-up. J Phys Ther Sci. 2022 Feb;34(2):167-171. doi: 10.1589/jpts.34.167. Epub 2022 Feb 23.
PubMed 35221522Racicki S, Gerwin S, Diclaudio S, Reinmann S, Donaldson M. Conservative physical therapy management for the treatment of cervicogenic headache: a systematic review. J Man Manip Ther. 2013 May;21(2):113-24. doi: 10.1179/2042618612Y.0000000025.
PubMed 24421621Al Khalili Y, Ly NK, Murphy PB. Cervicogenic Headache. 2022 Oct 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK507862/
PubMed 29939639Barmherzig R, Kingston W. Occipital Neuralgia and Cervicogenic Headache: Diagnosis and Management. Curr Neurol Neurosci Rep. 2019 Mar 19;19(5):20. doi: 10.1007/s11910-019-0937-8.
PubMed 30888540
Study at a glance
From the registry record, last updated by the sponsor on 8 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Cervicogenic Headache Among Lab Technicians
- ClinicalTrials.gov ID
- NCT07067242
- Acronym / sponsor ID
- 2020-GCUF079345
- Conditions
- Cervicogenic Headache
- Keywords
- Cervicogenic headache, Posture, Neck pain, Lab technicians
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 217 participants (actual)
- Lead sponsor
- Elite College of Management Sciences, Gujranwala, PakistanUniversity, hospital or other
- Study start
- 15 Apr 2025 (actual)
- Primary completion
- 30 Jun 2025 (actual)
- Study completion
- 3 Jul 2025 (actual)
- First posted
- 16 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to determine the prevalence of cervicogenic headache among lab technicians
Detailed description
Cervicogenic headache is a type of headache characterized by chronic hemi- cranial pain referred to the head from either the cervical spine or soft tissues within the neck .It reduces the quality of life .
Objective: The objective of this study is to determine the prevalence of cervico-genic headache among lab technicians in Gujranwala.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 30 to 44 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Lab technicians of Gujranwala
Key inclusion criteria (4 listed)
- Sitting duration of 3 or more than 3 hours
- Having neck pain for atleast1 month
- Consistant Unilateral headache
- Age 30 to 44
Key exclusion criteria (5 listed)
- Recent fracture
- Recent surgery
- Congenital conditions of cervical spine
- History of traumatic neck injuries or cervical spine surgery
- Diagnosis of primary headache disorders (e.g., migraines, tension-type headaches).(21)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Numeric Pain Rating Scale
Time frame: 4 weeks
The Numeric Pain Rating Scale (NPRS) is a commonly used tool to measure a patient's pain intensity in a quick and simple way. Patients are asked to rate their pain on a numeric scale from 0 to 10. 0 represents no pain, while 10 represents the worst possible pain
Self prepared questionnaire
Time frame: 4 weeks
To measure Cervicogenic headache associated disability
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 May 2026.
- Background: PubMed 29673262Young IA, Dunning J, Butts R, Cleland JA, Fernandez-de-Las-Penas C. Psychometric properties of the Numeric Pain Rating Scale and Neck Disability Index in patients with cervicogenic headache. Cephalalgia. 2019 Jan;39(1):44-51. doi: 10.1177/0333102418772584. Epub 2018 Apr 19.
- Background: PubMed 18031563Sjaastad O, Bakketeig LS. Prevalence of cervicogenic headache: Vaga study of headache epidemiology. Acta Neurol Scand. 2008 Mar;117(3):173-80. doi: 10.1111/j.1600-0404.2007.00962.x. Epub 2007 Nov 20.
- Background: PubMed 20974607Knackstedt H, Bansevicius D, Aaseth K, Grande RB, Lundqvist C, Russell MB. Cervicogenic headache in the general population: the Akershus study of chronic headache. Cephalalgia. 2010 Dec;30(12):1468-76. doi: 10.1177/0333102410368442. Epub 2010 May 19.
- Background18. Kanniappan, V., Abraham, S. S., & Veeragoudhaman, T. S. (2022). PREVALENCE OF CERVICOGENIC HEADACHE AMONG YOUNG POPULATION. International Journal of Research-GRANTHAALAYAH, 10(9), 14-26.
- Background: PubMed 30613496Almesned IS, Alqahtani NG, Alarifi JA, Alsaawy TN, Agha S, Alhumaid MA. Prevalence of primary headache among medical students at King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. J Family Med Prim Care. 2018 Nov-Dec;7(6):1193-1196. doi: 10.4103/jfmpc.jfmpc_240_18.
- Background: PubMed 29539610Muayqil T, Al-Jafen BN, Al-Saaran Z, Al-Shammari M, Alkthiry A, Muhammad WS, Murshid R, Alanazy MH. Migraine and Headache Prevalence and Associated Comorbidities in a Large Saudi Sample. Eur Neurol. 2018;79(3-4):126-134. doi: 10.1159/000487317. Epub 2018 Mar 14.
- Background10. Mathur, R., & Tegh, S. S. A Cross-Sectional Study on the Prevalence of Cervicogenic Headache Amongst University Students.
- Background: PubMed 35221522Fortner MO, Woodham TJ, Oakley PA, Harrison DE. Is the cervical lordosis a key biomechanical biomarker in cervicogenic headache?: a Chiropractic Biophysics(R) case report with follow-up. J Phys Ther Sci. 2022 Feb;34(2):167-171. doi: 10.1589/jpts.34.167. Epub 2022 Feb 23.
- Background: PubMed 24421621Racicki S, Gerwin S, Diclaudio S, Reinmann S, Donaldson M. Conservative physical therapy management for the treatment of cervicogenic headache: a systematic review. J Man Manip Ther. 2013 May;21(2):113-24. doi: 10.1179/2042618612Y.0000000025.
- Background: PubMed 29939639Al Khalili Y, Ly NK, Murphy PB. Cervicogenic Headache. 2022 Oct 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK507862/
- Background: PubMed 30888540Barmherzig R, Kingston W. Occipital Neuralgia and Cervicogenic Headache: Diagnosis and Management. Curr Neurol Neurosci Rep. 2019 Mar 19;19(5):20. doi: 10.1007/s11910-019-0937-8.
- Individual participant dataSharing planned: No
Related trials for Cervicogenic Headache
Not yet recruiting
Trigger Point Injection and Myofascial Release for Cervicogenic Headache
Cervicogenic Headache
Not yet recruiting
Comparative Effects of Dynamic Cupping and Facilitated Positional Release in Cervicogenic Headache
Cervicogenic Headache
Active, not recruiting
The Role Of Fascia And Breathing Exercises In The Treatment Of Cervicogenic Headache
Cervicogenic Headache
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Knee Osteoarthritis(OA)
Myofascial Trigger Points, Migraine
Recruiting
Comparative Effects of Post Isometric Relaxation and Reciprocal Inhibition in Individuals With Cervicogenic Headache.
Post Traumatic Headache, Cervicogenic Headache
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Rukhma Mauzzam principal investigator
Elite College of Management Science
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cervicogenic Headache, run by Elite College of Management Sciences, Gujranwala, Pakistan at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Numeric Pain Rating Scale (time frame: 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07067242, which also lists 11 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026.